Position in TERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,575,400
New position
Shares Held
257,500
first reported quarter
Ownership
0.223%
of shares outstanding
% of Portfolio
7.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026HARVEST MANAGEMENT LLC holds $32,146,723 across 8 Biotechnology names. TERN ranks #1 (42.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
This page
|
257,500 | $13,575,400 | |
| 2 | ACLX |
Arcellx, Inc.
|
50,000 | $5,741,000 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
247,400 | $3,577,404 | |
| 4 | CNTA |
Centessa Pharmaceuticals plc
|
80,000 | $3,177,600 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
70,000 | $2,816,100 | |
| 6 | DAWN |
Day One Biopharmaceuticals, Inc.
|
75,000 | $1,608,000 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,524 | $926,209 | |
| 8 | CYTK |
Cytokinetics Inc
|
11,000 | $725,010 |
All Filings in TERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,575,400 | 257,500 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||